Feedback on the WHO draft approach towards development of a global regulatory framework for CGT

The WHO document has been prepared for the purpose of inviting comments and suggestions on the proposals contained therein, which will then be considered by the Expert Committee on Biological Standardization (ECBS). Publication of this early draft is to provide information about the proposed document- WHO approach towards the development of a global regulatory  framework for cell and gene therapy products, to a broad audience and to ensure the transparency of the consultation process.

The outcome of the deliberations of the Expert Committee will be published in the WHO  Technical Report Series.  A cross sub-team team of 18 members from 14 companies submitted feedback on WHO Approach towards the development of a global regulatory framework for cell and gene therapy products(document WHO/BS/2022.2424)

This document is reserved for the use of BioPhorum members only.

I don't have access to this document

Make a selection below and submit your request. We will get back to you ASAP.

My company would like to become a member

If you're not sure if your company is a member of this Phorum, or if you would like to enquire on behalf of your company about becoming a member, please see our membership page.

Preview